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ABSTRACT
Background and Objectives: Aspiration thrombectomy (AT) during primary percutaneous coronary intervention (PCI) is 
an effective adjunctive therapy for ST-segment elevation myocardial infarction (STEMI). An elevated neutrophil count in STE-
MI is associated with microvascular dysfunction and adverse outcomes. We evaluated whether AT can improve microvascu-
lar dysfunction in patients with STEMI and an elevated neutrophil count. Subjects and Methods: Seventy patients with 
STEMI undergoing primary PCI from August 2007 to February 2009 in our institution were classified by tertiles of neutro-
phil count on admission (<5,300/mm
3, 5,300-7,600/mm
3, and >7,600/mm
3). The angiographic outcome was post-procedur-
al thrombolysis in myocardial infarction (TIMI) flow grade. Microvascular dysfunction was assessed by TIMI myocardial 
perfusion (TMP) grade and ST-segment resolution on electrocardiography 90 minutes after PCI. The clinical outcome was ma-
jor adverse cardiac event (MACE), defined as cardiac death, re-infarction, and target lesion revascularization at 9 months. Re-
sults: There were no significant differences in the clinical characteristics and pre- and post-procedural TIMI flow grades be-
tween the neutrophil tertiles. As the neutrophil count increased, a lower tendency toward TMP grade 3 (83% vs. 52% vs. 
54%, p=0.06) and more persistent residual ST-segment elevation (>4 mm: 13% vs. 26% vs. 58%, p=0.005) was observed. The 
9-month MACE rate was similar between the groups. On subgroup analysis of AT patients (n=52) classified by neutrophil 
tertiles, the same tendency toward less frequent TMP grade 3 (77% vs. 56% vs. 47%, p=0.06) and persistent residual ST-seg-
ment elevation (>4 mm: 12% vs. 28% vs. 53%, p=0.05) was observed as neutrophil count increased. Conclusion: A higher 
neutrophil count at presentation in STEMI is associated with more severe microvascular dysfunction after primary PCI, 
which is not improved with AT. (Korean Circ J 2011;41:68-75)
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Introduction
Primary percutaneous coronary intervention (PCI) is ef-
fective in opening infarct-related arteries in patients with ST-
segment elevation myocardial infarction (STEMI). Aspira-
tion thrombectomy (AT) is an effective adjunctive therapy for 
patients with STEMI, which reduces large thrombotic bur-
den by improving coronary reperfusion.
1-3)
However, restoration of epicardial coronary flow in patients 
with STEMI does not necessarily lead to restoration of micro-
vascular perfusion and protection of myocardial dysfunc-
tion. For this reason, identifying factors affecting microvas-
cular perfusion has gained importance to reduce myocardial 
dysfunction.
Neutrophils, together with platelets, have recently been de-
scribed as predictors of impaired left ventricular (LV) func-
tion and worse clinical prognosis in patients with STEMI. The 
suggested pathologic mechanisms involving neutrophils are 
microvascular plugging, spasm, endothelial swelling, and in-Hye Young Lee, et al.   69
flammatory response by pro-inflammatory cytokines release, 
all of which eventually lead to impairment of microvascular 
perfusion during acute myocardial ischemia and following 
reperfusion therapy.
1)4-10) However, it is unclear whether AT dur-
ing primary PCI can prevent or reduce microvascular damage 
in patients with elevated neutrophil counts. 
The objective of this study was to determine the effect of neu-
trophil count on microvascular dysfunction, and the effect of 
AT on improving microvascular dysfunction during primary 
PCI in patients with STEMI.
Subjects and Methods
Study population
From August 2007 to February 2009, the medical records of 
74 consecutive patients who underwent primary PCI for STE-
MI were reviewed. STEMI was defined as symptoms or signs 
suggesting acute myocardial ischemia lasting >30 minutes, 
and ST-segment elevation of ≥0.2 mV in the precordial leads 
and 0.1 mV in limb leads in ≥2 contiguous leads on 12-lead 
electrocardiography (ECG). Patients pre-treated with fibri-
nolytic therapy and with co-morbidities which may affect 
blood cell counts, such as active infections, acute metabolic de-
compensation, chronic renal failure (defined as a serum cre-
atinine level ≥2 mg/dL), advanced liver disease, malignan-
cies, autoimmune diseases, and those currently under steroid 
treatment, were excluded (4 patients). As a result, 70 patients 
were enrolled in this study. All patients gave informed con-
sent to participate in the study before undergoing coronary 
angiography and AT. 
All patients had blood drawn for white blood cell (WBC) 
and differential counts, creatine kinase-myocardial band (CK-
MB), troponin-T (Tn-T), and high sensitive C-reactive pro-
tein (hs-CRP) before primary PCI, and lipid profiles the next 
morning. An automated hematology analyzer (Sysmex SE-
2100; Sysmex Corporation, Kobe, Japan) measured total WBC 
and neutrophil counts. The plasma concentrations of hs-CRP 
were measured by fully automated latex-enhanced immuno-
turbidmetric assays (Olympus AU 680; Munich, Germany). 
Patients were classified into tertiles of neutrophil counts on 
admission (<5,300/mm
3, 5,300-7,600/mm
3, and >7,600/mm
3) 
to compare microvascular dysfunction as the neutrophil count 
increased. 
Patients were also compared based on whether or not AT 
was performed, and subgroups of patients who underwent 
AT were classified by neutrophil tertiles and analyzed. 
 
Primary percutaneous coronary intervention, 
aspiration thrombectomy, and analysis of angiography
Primary angioplasty of the culprit lesion was performed 
by standard techniques via the transfemoral approach with a 
6-Fr sheath and catheters and a loading dose of intravenous 
heparin (6,000 IU). Antiplatelet therapy was consisted of a 
loading dose of aspirin (300 mg) and clopidogrel (300-600 mg), 
and a subsequent maintenance dose of aspirin (100 mg) and 
clopidogrel (75 mg). The first procedural step involved pass-
ing a guidewire through the culprit lesion, then advancing 
the 6-Fr guiding compatible Thrombuster aspiration catheter 
(crossing profile, 5.1 Fr; Kaneca Inc. Tokyo, Japan) was insert-
ed into the target coronary segment based on angiographic 
selection criteria, when the pre-procedural thrombolysis in 
myocardial infarction (TIMI) flow grade was 0-1, or the large 
visible thrombotic burden existed in the infarct-related ar-
tery was >2.5 mm in diameter on coronary angiogram. AT was 
defined as ‘technically successful’ when the thrombectomy ca-
theter was easily placed distal to the target lesion and consid-
ered ‘effective’, when grossly-visible thrombotic material was 
retrieved in the aspirated sample. After primary PCI, post-
procedural TIMI flow grades were assessed for angiographic 
outcome, and TIMI myocardial perfusion (TMP) grades for 
microvascular dysfunction.
11) The coronary angiograms were 
reviewed by two unbiased cardiologists. Glycoprotein IIb/IIIa 
inhibitor (GPI) was administered at the discretion of the at-
tending physician. 
Analysis of electrocardiography
A 12-lead ECG was acquired at presentation and 90 min-
utes after PCI, and the ST-segments on the post-procedural 
ECG was compared with the ECG at presentation. The degree 
of resolution of ST-segment elevation was categorized as com-
plete (>70%), partial (30-70%), or none (<30%) according to the 
TAPAS study. Residual ST-segment elevation was classified into 
3 groups (<1 mm, 1-4 mm, and >4 mm) and assessed.
Study endpoints
The angiographic outcome was post-procedural TIMI flow 
grades. Microvascular dysfunction was assessed by TMP grades 
and ST-segment resolution on ECG 90 minutes after primary 
PCI. The clinical outcome was major adverse cardiac event 
(MACE), defined as cardiac death, re-infarction, and target 
lesion revascularization (TLR) 9 months after the index pro-
cedure. Cardiac death was defined as death due to myocardial 
infarction, cardiac perforation or tamponade, arrhythmia, dea-
th due to a complication of the procedure, and any death in 
which cardiac cause could not be excluded. Re-infarction was 
defined as recurrent symptoms with new ST-segment eleva-
tion and elevation of cardiac markers 2-fold more than the 
upper limit of normal range. TLR was defined as ischemia-
driven revascularization of the infarct-related artery by PCI, 
or bypass surgery during the follow-up period. 
Statistical analysis 
Data were reported as the mean±standard deviation for 
continuous variables and as percentages for categorical vari-70   Aspiration Thrombectomy on Microvascular Dysfunction in STEMI
ables. For testing of significance, continuous variables were 
compared using an independent t-test, and categorical data 
were compared using a chi-square test. Statistical comparisons 
were performed using Statistical Package for the Social Sci-
ences (SPSS, version 12.0; SPSS Inc., Chicago, IL, USA). All sig-
nificant tests were 2-sided, and the results were considered 
statistically significant when p≤0.05.
Results
The baseline clinical characteristics of the 70 patients clas-
sified by tertiles of the neutrophil count at presentation are 
listed in Table 1. The median neutrophil count was 6,220/mm
3 
(range, 2,090-22,100/mm
3). For clinical characteristics, there 
were no significant differences in age, gender, prevalence of 
diabetes, hypertension, history of smoking, body mass index, 
symptom-to-door time, and door-to-balloon time between 
the neutrophil tertiles. There were no significant differences 
at presentation with respect to CK-MB, Tn-T, hemoglobin, 
total cholesterol, high density lipoprotein-cholesterol, triglyc-
erides, low density lipoprotein-cholesterol levels and platelet 
counts between the three groups. However, higher neutrophil 
tertiles had significantly higher levels of peak CK-MB (173± 
143 ng/dL vs. 258±179 ng/dL vs. 298±179 ng/dL, p=0.04) and 
hs-CRP (0.4±0.6 mg/dL vs. 1.1±1.7 mg/dL vs. 3.4±6.4 mg/dL, 
p=0.04). 
AT was performed in 52 of 70 patients (74%) and GPI was 
administered in 8 of 70 patients (11%). The frequency of per-
forming AT and the use of GPI were not significantly differ-
ent between the neutrophil tertiles. Technical success of AT 
was achieved in all patients, and effective AT was achieved 
in 43 of 52 patients (83%).
Comparison of angiographic, electrocardiographic, and cli-
nical outcomes between neutrophil tertiles is summarized in 
Table 2. Pre- and post-procedural TIMI flow grades were simi-
lar between neutrophil tertiles, and a final TIMI flow grade of 
2-3 was achieved in all patients. However, a TMP grade of 3 was 
marginally less frequently achieved in the higher neutrophil 
Table 1. Baseline characteristics of patients grouped by tertiles of neutrophil counts
Variables
Neutrophil counts (/mm
3)
p
<5,300 (n=23) 5,300-7,600 (n=23) >7,600 (n=24)
Age (years) 60.0±11.1 65.3±13.6 58.5±10.30 0.13
Gender, male (n, %) 18 (78.3) 17 (73.9) 19 (79.2) 0.90
Diabetes (n, %) 06 (26.1) 08 (34.8) 08 (33.3) 0.79
Hypertension (n, %)* 11 (47.8) 11 (47.8) 15 (62.5) 0.50
Smoking (n,%)  11 (47.8) 12 (52.2) 16 (66.7) 0.39
Body mass index (m
2/kg) 24.8±2.60 24.6±3.50 23.2±2.600 0.13
Symptom-to-balloon time (minute) 495.9±870.5 259.5±185.5 560.5±1041.6 0.58
Symptom-to-door time (minute) 296.8±951.7 264.6±202.8 489.0±974.60 0.54
Door-to-balloon time (minute) 78.9±44.9 76.0±31.7 80.7±24.80 0.07
Initial CK-MB (ng/dL) 36.5±18.0 23.8±35.2 38.7±97.00 0.82
Initial TnT (ng/dL) 0.68±1.70 0.21±0.36 1.52±4.300 0.26
CK-MB peak (ng/dL) 173.4±143.4 258.1±179.1 298.0±179.20 0.04
Hemoglobin (g/dL) 14.4±1.40 14.5±2.00 14.3±1.800 0.80
Platelet (/mm
3) 227.9±50.00 229.9±53.00 230.0±49.700 0.98
Hematocrit (%) 42.4±3.90 58.5±8.40 41.9±5.100 0.42
Total cholesterol (mg/dL) 171.0±26.50 173.4±33.00 179.1±35.400 0.69
Triglycerides (mg/dL) 113.1±53.50 119.3±68.00 115.2±49.100 0.93
HDL-C (mg/dL) 41.6±7.40 43.5±14.1 38.9±8.800 0.34
LDL-C (mg/dL) 112.8±21.60 113.2±21.90 118.4±23.700 0.61
hs-CRP (mg/dL) 0.4±0.6 1.1±1.7 3.4±6.40 0.04
LVEF (%) 58.9±10.8 52.2±10.4 53.5±6.700 0.06
ST-segment resolution (%) 78.2±25.0 71.1±30.6 65.8±26.50 0.30
Aspiration thrombectomy (n, %) 17 (73.9) 18 (78.3) 17 (70.8) 0.84
Glycoprotein IIb/IIIa inhibitor (n, %) 1 (4.3) 2 (8.7) 05 (20.8) 0.18
Data are expressed as the mean±SD and number (percentage). *Blood pressure >140/90 mmHg or anti-hypertensive medication. CK-MB: cre-
atine-kinase-MB, Tn-T: troponin-T, HDL-C: high density lipoprotein-cholesterol, LDL-C: low density lipoprotein-cholesterol, hs-CRP: high-
sensitivity C-reactive protein, LVEF: left ventricular ejection fractionHye Young Lee, et al.   71
tertiles (83% vs. 52% vs. 54%, p=0.06) (Fig. 1A). Although ST-
segment resolution rate was not significantly different (p=0.20), 
residual ST-segment elevation was significantly persistent with 
higher neutrophil tertiles (>4 mm; 13% vs. 26% vs. 58%, p= 
0.005) (Fig. 1C). MACEs occurred in 5 of 70 patients (7.1%), 
including 2 cardiac deaths and 3 TLRs during 9 months of 
follow-up. There was no significant difference in the MACE 
rate between neutrophil tertiles (Table 2).
Comparison of patients who did and did not 
undergo aspiration thrombectomy
Of 70 patients, AT was performed in 52 patients (AT+ gr-
Table 2. Angiographic, electrocardiographic, and clinical outcomes according to neutrophil counts in all patients
Variables
Neutrophil count (/mm
3)
p
<5,300 (n=23) 5,300-7,600 (n=23) >7,600 (n=24)
Pre-procedural TIMI (%) 0.71
0 09 (39.1) 15 (65.2)  15 (62.5)
1 04 (17.4) 2 (8.7) 03 (12.5)
2 08 (34.8) 05 (21.7) 05 (20.8)
3 2 (8.7) 1 (4.3) 1 (4.2)
Post-procedural TIMI  (%) 0.13
2 0 (0)0. 2 (8.7) 04 (16.7)
3 23 (100) 21 (91.3) 20 (83.3)
TMP grade (%) 0.06
2 04 (17.4) 11 (47.8) 11 (45.8)
3 19 (82.6) 12 (52.2)  13 (54.2)
ST-segment resolution (%) 0.20
None (<30%) 1 (4.3) 3 (13). 03 (12.5)
Partial (30-70%) 06 (26.1) 06 (26.1) 12 (50)0.
Complete (>70%) 16 (69.6) 14 (60.9) 09 (37.5)
Residual ST-segment elevation (%) 0.005
<1 mm 13 (56.5) 09 (39.1) 09 (37.5)
1-4 mm 07 (30.4) 08 (34.8) 1 (4.2)
>4 mm 3 (13). 06 (26.1) 14 (58.3)
MACE (%) 0.71
Cardiac death 0 1 (4.3) 1 (4.2)
TLR 1 (4.3) 1 (4.3) 1(4.2)
Re-infarction 0 0 0
Data are expressed as number (percentage). TIMI: thrombolysis in myocardial infarction, PCI: percutaneous coronary intervention, TMP 
grade: TIMI myocardial perfusion grade, MACE: major adverse cardiac outcome, TLR: target lesion revascularization
Fig. 1. TMP grades, ST-segment resolution, and residual ST-segment elevation in all patients. A: TMP grade. B: ST-segment resolution. C: re-
sidual ST-segment elevation. TMP: thrombolysis in myocardial infarction myocardial perfusion.
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oup) and not performed in 18 patients (AT- group). Table 3 sum-
marizes the comparison between the two groups. In the AT+ 
group, 41 patients (79%) had a pre-procedural TIMI flow 
grade of 0-1 and the remaining 11 patients (21%) had a TIMI 
flow grade of 2-3 with large visible thrombi. The pre-proce-
dural TIMI flow grade of 0-1 was significantly worse in the 
AT+ group than the AT- group (79% vs. 39%, p=0.01), wh-
ich suggested a greater thrombotic burden requiring AT. In 
the AT- group (n=18), the pre-procedural TIMI flow grade 
was 0-1 in 7 patients (grade 0, n=5; and grade 1, n=2) but AT 
was not performed because upon the guidewire crossing the 
culprit lesion, a TIMI flow grade of 3 was immediately rest-
ored without grossly-visible thrombus, which suggested very 
small or negligible thrombus not requiring AT. Other than 
pre-procedural TIMI flow, there were no significant differ-
ences in baseline characteristics, laboratory findings, post-
procedural TIMI flow grades, TMP grades, and ST-segment 
resolution rates between the two groups. 
Subgroup analysis of patients undergoing aspiration 
thrombectomy classified by neutrophil tertiles
Subgroup analysis was performed on the AT+ group (n= 
52) divided by neutrophil tertiles (Table 4) (Fig. 2) to evaluate 
the effect of AT on patients with elevated neutrophil counts. 
There were no significant differences in pre- and post-proce-
dural TIMI flow grades and the ST-segment resolution rates 
(Fig. 2B) between the neutrophil tertiles. However, the high-
er the neutrophil counts, a lower tendency toward TMP grade 
3 (77% vs. 56% vs. 47%; p=0.06) (Fig. 2A) was observed. Re-
sidual ST-segment elevation was persistent in the higher 
neutrophil tertiles (>4 mm; 12% vs. 28% vs. 53%, p=0.05) 
(Fig. 2C). 
Table 3. Comparison of patients with and without aspiration thrombectomy
Variables No AT (n=18) AT (n=52) p
Age (years) 59.7±11.7 61.8±12.1 0.53
Gender, male (n, %) 14 (77.8) 40 (76.9) 0.91
Neutrophil (/mm
3) 6,967±2,960 7,380±4.020 0.64
Diabetes (n, %) 0 7 (38.9) 15 (28.8) 0.55
Hypertension (n, %)* 10 (55.6) 27 (51.9) 0.79
Smoking (n, %) 11 (61.1) 28 (53.8) 0.59
CK-MB peak (ng/dL) 194.0±161.7 261.2±176.2 0.14
hs-CRP (mg/dL) 1.3±2.2 1.7±4.5 0.67
LVEF (%) 56.1±10.5 54.2±9.60 0.48
Pre-procedural TIMI (%) 0.01
0 05 (27.8) 34 (65.4)
1 02 (11.1) 07 (13.5)
2 09 (50.0) 09 (17.3)
3 02 (11.1) 2 (3.8)
Post-procedural TIMI  (%) 0.59
2 1 (5.6) 5 (9.6)
3 17 (94.4) 47 (90.4)
TMP grade (%) 0.40
2 05 (27.8) 21 (40.4)
3 13 (72.2) 31 (59.6)
ST-segment resolution (%) 0.13
None (<30%) 04 (22.2) 3 (5.8)
Partial (30-70%) 05 (27.8) 19 (36.5)
Complete (>70%) 09 (50.0) 30 (57.7)
Residual ST-segment elevation (%) 0.81
<1 mm 07 (38.7) 24 (46.2)
1-4 mm 04 (22.2) 12 (23.1)
>4 mm 07 (38.9) 16 (30.8)
Data are expressed as the mean±SD and number (percentage). *Blood pressure >140/90 mmHg or anti-hypertensive medication. AT: aspiration 
thrombectomy, CK-MB: creatine-kinase-MB, Tn-T: troponin-T, hs-CRP: high-sensitivity C-reactive protein, LVEF: left ventricular ejection 
fraction, TIMI: thrombolysis in myocardial infarction, TMP grade: TIMI myocardial perfusion gradeHye Young Lee, et al.   73
Discussion
A unique contribution of our study is the assessment of 
the effect of AT on microvascular dysfunction, in terms of in-
itial neutrophil counts in patients with STEMI. A major find-
ing was that elevated neutrophil counts at the time of admis-
sion in patients with STEMI is associated with more severe 
microvascular dysfunction, even after AT. 
Several randomized trials of patients with STEMI demon-
strated that manual thrombus aspiration improved myocar-
Table 4. Angiographic, electrocardiographic, and clinical outcomes according to neutrophil counts in patients undergoing aspiration throm-
bectomy
Variables
Neutrophil count (/mm
3)
p
<5,300 (n=17) 5,300-7,600 (n=18) >7,600 (n=17)
Pre-procedural TIMI (%) 0.52
0 08 (47.1) 13 (72.2)  13 (76.5)
1 04 (23.5) 1 (5.6) 02 (11.8)
2 04 (23.5) 03 (16.7) 02 (11.8)
3 1 (5.9) 1 (5.6) 0 (0)
Post-procedural TIMI  (%) 0.21
2 0 (0)0. 02 (11.1) 03 (17.6)
3 17 (100) 16 (88.9) 14 (82.4)
TMP grade (%) 0.06
2 04 (23.5) 08 (44.4) 09 (52.9)
3 13 (76.5) 10 (55.6) 08 (47.1)
ST-segment resolution (%) 0.49
None (<30%) 1 (5.9) 1 (5.6) 1 (5.9)
Partial (30-70%) 04 (23.5) 06 (33.3) 09 (52.9)
Complete (>70%) 12 (70.6) 11 (61.1) 07 (41.2)
Residual ST-segment elevation (%) 0.05
<1 mm 10 (58.8) 07 (38.9) 07 (41.2)
1-4 mm 05 (29.4) 06 (33.3) 1 (5.9)
>4 mm 02 (11.8) 05 (27.8) 09 (52.9)
MACE (%) 0.81
Cardiac death 0 1 (5.9) 1 (5.9)
TLR 1 (5.9) 1 (5.6) 1 (5.9)
Re-infarction 0 0 0
Data are expressed as the number (percentage). TIMI: thrombolysis in myocardial infarction, PCI: percutaneous coronary intervention, TMP: 
TIMI myocardial perfusion
Fig. 2. TMP grades, ST-segment resolution, and residual ST-segment elevation in patients undergoing aspiration thrombectomy. A: TMP grade. 
B: ST-segment resolution. C: residual ST-segment elevation. TMP: thrombolysis in myocardial infarction myocardial perfusion.
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dial perfusion, when compared to conventional PCI.
2)12) The 
role of AT has been particularly emphasized in patients with 
high-risk angiographic characteristics.
13) Increased neutro-
phil count has been reported to be associated with increased 
risk of adverse clinical events and impaired microvascular 
perfusion in patients with acute myocardial infarction.
9)
Recently Kirtane et al.
14) and Mehta et al.
15) reported that an 
elevated neutrophil count correlated with reduced patency of 
the epicardial coronary arteries after thrombolysis and impair-
ed microvascular perfusion with longer corrected TIMI frame 
count, possibly as a result of neutrophil-mediated microvascu-
lar plugging. Sezar et al.
8) also reported an association between 
neutrophilia on admission and severe microvascular dysfunc-
tion evaluated 48 hours after primary PCI. It is known that dur-
ing myocardial ischemia-reperfusion, neutrophils cause cap-
illary plugging in coronary microcirculation and damage en-
dothelial function, resulting in reduced coronary vasodilator 
reserve.
16-18) A growing body of evidence also suggests that in-
flammation plays an important role in acute coronary syndro-
me, leading to progression of atherosclerosis, plaque rupture, 
and thrombotic occlusion. Neutrophils release pro-inflamma-
tory cytokines, which cause local and systemic inflammatory 
responses, resulting in microvascular swelling and blood flow 
impairment.
12)19)
In the current study, patients with higher neutrophil ter-
tiles had higher levels of blood peak CK-MB, indicating more 
severe myocardial necrosis. Microvascular dysfunction as-
sessed by TMP grades and residual ST-segment changes were 
also more severe as the neutrophil counts increased, and the 
tendency continued, even with AT. The above findings sug-
gest that higher neutrophil counts in patients with STEMI is 
associated with more severe microvascular dysfunction, which 
was not successfully treated, even with AT. 
The role of inflammation in the pathophysiology of STEMI 
should be emphasized. In our study, patients with higher neu-
trophil counts had higher levels of hs-CRP. Consistent with 
previous studies, an elevated hs-CRP implies increased in-
flammation mediated by the endothelium and blood cells, 
including neutrophils, in patients with STEMI may be asso-
ciated with more atheromas and myocardial injury,
16-18) and 
further aggravate myocardial damage, even after removal of 
thrombi in the coronary circulation. Both WBC count and CRP 
level are markers of inflammation and predictors of outcomes 
after STEMI, but the association between neutrophils and 
adverse clinical outcomes is known to be independent of CRP.
20)
Another interesting finding is that the prevalence of per-
sistent residual ST-segment elevation on ECG after PCI was 
significantly higher in the elevated neutrophil tertiles, which 
remained unchanged after AT. This suggests that AT was un-
able to sufficiently prevent microvascular dysfunction in pa-
tients with elevated neutrophil counts.
Several studies have suggested that neutrophil counts at the 
time of initial presentation in patients with STEMI can predict 
outcomes at both short- and long-term follow-up evalua-
tions.
1)4-10)21-24) There was no significant difference in the 
9-month MACE rate between the neutrophil tertiles. The rea-
son why a higher neutrophil count did not result in worse 
clinical outcomes may be attributed to the low incidence of 
MACEs (7%) in our study. This finding was also consistent 
with another study which revealed a discrepancy between 
reperfusion and clinical outcome in patients with STEMI af-
ter AT.
25) A further study is needed to clarify in this regard.
Early and sustained restoration of flow into the infarct-re-
lated artery is the aim of reperfusion therapy in patients with 
STEMI. AT and GPIs during primary PCI have been the ma-
instay of adjunctive treatment in sustaining reperfusion and 
improving microvascular dysfunction. However, in our st-
udy AT had a limited role in improving microvascular dys-
function in patients with higher neutrophil counts. 
This study had several inherent limitations. It was a single 
center study and the patient population was small. For detailed 
analysis, such as ST segment changes and TMP grades, we were 
unable to use a large registry data. In addition, AT was selec-
tively performed, rather than randomized. Although a large 
portion of patients in our study required AT, we believe that 
routine aspiration is not always indicated in primary PCI. Th-
erefore, we performed AT in select patients with large throm-
botic burdens at the discretion of experienced cardiologists. 
In our opinion, that is the more realistic way to evaluate the 
effect of AT in high-risk patients. Without randomization of 
aspiration, however, we were able to assess the effect of AT ac-
cording to the neutrophil tertiles, which generated the key find-
ings in this study. 
Further large-scale randomized trials is needed to validate 
our findings, and define the role of AT in improving microvas-
cular dysfunction in high risk patients with STEMI.
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